Volume 14 - Issue 4 - April, 2002

Is Noncontact Normothermic Wound Therapy Cost Effective for the Treatment of Stages 3 and 4 Pressure Ulcers?

Introduction

     Chronic pressure ulcers are significant health problems, especially for patients in long-term care facilities. Pressure ulcers reduce quality of life and may lead to infection, pain, and death. Estimates of the prevalence of pressure ulcers in nursing home patients range from 3 to 28 percent,1–3 with an annual incidence of 2 to 13 percent.4–6 Reducing the proportion of nursing home residents with pressure ulcers is receiving increasing public health attention and is one of the Healthy People 2010 Objectives.7

  &nbs



In-Vitro Mechanisms of Cell Proliferation Induction: A Novel Bioactive Treatment for Accelerating Wound Healing

Introduction

Over the past several years, much has been learned regarding the molecular and physiological bases of wound healing,1 as well as the causes of various chronic wounds, such as pressure ulcers. Recent cellular and molecular studies have substantially increased our understanding of the elegant cascade of signaling events necessary for the wound healing process.1–11 For example, several important biochemical mediators of cell migration and growth have been identified that are involved in tissue reformation.6,12,13 It is understood that, in many instances, th



Successful Treatment of Recalcitrant, Diabetic Heel Ulcers with Topical Becaplermin (rhPDGF-BB) Gel

Introduction

Diabetic foot ulceration is a major complication of diabetes mellitus.1–5 Among the 10 to 15 million diabetic patients, two to three percent will develop foot ulcers each year, and approximately 15 percent will develop foot ulcers during their lifetimes.4,6–8 The four percent of the US population with diagnosed diabetes mellitus constitute 46 percent of the approximately 162,500 annual hospitalizations for foot ulcers.4,7 Foot ulcers precede 85 percent of all nontraumatic, lower-limb amputations, and half of all nontraumatic, lower-limb amputations in



Venous Stasis Ulcer Complicated by Calcinosis Cutis

Diagnostic Dilemmas (CME and CPME accredited)

Department Editor
Tania Phillips, MD, FRCPC

Overall Learning Objective: The physician or podiatrist participant will develop a rational approach to the evaluation and treatment of a variety of uncommon wounds and will have an increased awareness of the differential diagnosis of cutaneous wounds and the systemic diseases associated with these wounds.

Submissions: To submit a case for consideration in Diagnostic Dilemmas, e-mail or write to: Executive Editor, WOUNDS, 83 General Warren Blvd., Suite 100, Malvern, PA 1935



April 2002

First Single-Use Test for Hemoglobin A1c Now Available for In-Office and Prescription Home Use

Metrika Inc. recently announced commercial availability of its flagship A1cNow™ diabetes monitor, the first single-use device for measuring hemoglobin A1c (HbA1c)—the gold standard indicator of diabetes control. Using the simple finger-stick test, healthcare professionals can now obtain immediate, quantitative HbA1c results during the office visit, and offer their patients the ability to monitor this key health indicator at home for the very first time.

The disposable, pager-sized A1cNow Mo



April 2002

biolitec Clinical Study: Wound Healing by Laser Light

biolitec, Inc. is currently seeking investigators and subjects for a new clinical study to assess the efficacy of laser light at the 980 nm wavelength in healing all diabetic foot wounds. The selection process for qualified investigators is underway with the objective of establishing several study sites in the United States.

The study entails the application of laser light at the 980 nm wavelength—using the biolitec Ceralas D diode laser and a special collimating handpiece—to subjects’ wounds over the course of several weeks or